Early referral and control of disease’s flares prevent Orthopedic and Hand Surgery Indication (OHSI) in a dynamic cohort of Hispanic early rheumatoid arthritis patients

Table 2 OHSI patient’s description

Number of patient	DR months	Baseline DAS28	OHSI DAS28	Follow-up to OHSI, months	Treatment at OHSI	Surgical indication
1^a	7.3	5.6	3.4	110	MTX + SUL + LEF + PDN	Left hip arthroplasty
2^a	4.7	7.2	2.4	114	MTX + PDN	Right knee arthroplasty
3^a	7.6	8.7	6.4	68	MTX + PDN	Left hip arthroplasty
4^a	1	7.1	3.0	132	MTX + PDN	Hemi-resection of the distal ulna and extensor tendon’s reconstruction (right hand)
5	8.8	7.8	2.4	146	MTX + PDN	Extensor tendon’s reconstruction (left hand)
6	6	5.8	3.4	124	CLQ + SUL + PDN	Right hip arthroplasty
7	10.5	5.3	2.5	72	MTX + CLQ + PDN	Right knee arthroplasty
8^a	6.7	4.6	5.2	114	AZA + PDN	Extensor tendon’s reconstruction (left hand)
9^a	9.5	8.0	2.3	66	MTX + PDN	Left shoulder arthroplasty
10^a	7.2	7.1	2.6	52	MTX + CLQ + SUL + PDN	Right hand synovectomy
11	12.1	5.3	2.2	14	MTX + CLQ + SUL	Right knee arthroplasty
12^a	8.5	6.8	2.5	14	MTX + CLQ + SUL + PDN	Left hip arthroplasty

DAS28 Disease activity score (28 joints evaluated), MTX methotrexate, SUL sulphasalazine, LEF leflunomide, PDN prednisone, CLQ chloroquine, AZA azathioprine, F female, M male, DR months of symptom’s disease duration up to cohort baseline evaluation, DAS28 disease activity
^aPatients already intervened

ISSN: 1471-2474